Trade COLL anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Collegium Pharmaceutical, Inc. (COLL) is trading at US$23.53, down 0.72% today as of Sep 4, 16:00 EDT. The company has a market capitalisation of US$840.39M. Over the past 52 weeks, COLL has traded between US$23.37 and US$50.79. On Syfe you can trade COLL with $0 commission and add it to your watchlist.
| Previous close | US$23.70 |
|---|---|
| Market cap | US$840.39M |
| P/E ratio | 3.37 |
| 52-week range | US$23.37 – US$50.79 |
| Volume | 884.07K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Collegium Pharmaceutical, Inc.
Collegium Pharmaceutical, Inc. is a dynamic, biopharmaceutical company delivering medicines with formulation and delivery innovation for people living with complex central nervous system and pain conditions. The firm has spent more than a decade proving that responsible stewardship and bold, science-backed approaches can redefine what treatment looks like in categories too often shaped by complexity and misconceptions. Its products include Xtampza ER, Nucynta ER and Nucynta IR, Belbuca, and Symproic. The company was founded by Michael Thomas Heffernan in April 2002 and is headquartered in Stoughton, MA.
Year: 2015
--GUIDANCE: (COLL) Collegium Pharmaceutical Expects 2026 Net Product Revenue Range $825M to $855M
Aug 6, 11:42 AM · MT Newswires
-- Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Reports Q2 Revenue $199.9M, vs. FactSet Est of $199.6M
Aug 6, 11:34 AM · MT Newswires
-- Earnings Flash (COLL) Collegium Pharmaceutical, Inc. Posts Q2 Adjusted EPS $1.92 per Share, vs. FactSet Est of $1.72
Aug 6, 11:34 AM · MT Newswires
Collegium Pharmaceutical to Relocate HQ to One Lincoln in Boston
Jul 20, 2:00 PM · MT Newswires
Collegium Pharmaceutical, Inc. (COLL) stock is trading at US$23.53, -0.72% from the previous close of US$23.70.
The market cap for Collegium Pharmaceutical, Inc. (COLL) stock is approximately US$840.39M.
The price-to-earnings ratio for Collegium Pharmaceutical, Inc. (COLL) is 3.37, based on the latest reported earnings.
The 52-week high for Collegium Pharmaceutical, Inc. (COLL) stock is US$50.79.
The 52-week low for Collegium Pharmaceutical, Inc. (COLL) stock is US$23.37.
Collegium Pharmaceutical, Inc. (COLL) does not currently pay a dividend.
Stay on top of COLL
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
